Srinivas Akkaraju - Director, 10%+ Owner at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

Srinivas Akkaraju - trading volume in the past year for Kalaris Therapeutics, Inc.

Holdings reported by Srinivas Akkaraju for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,968,234 $108,037,104 $9.85 18 Dec 2025 By Samsara BioCapital, L.P.
Common Stock 1,979,847 $20,630,005 $10.42 18 Dec 2025 By Samsara Opportunity Fund, L.P.
Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct Common Stock

Transactions reported by Srinivas Akkaraju for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.